U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512154) titled 'Precision Radiotherapy Enabled by Molecular MRI' on March 30.
Brief Summary: This is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Brain Cancer
Intervention:
RADIATION: Amide proton transfer radiotherapy
New APT-RT regimen
RADIATION: Standard radiotherapy
Standard two-phase RT
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sidney Kimmel Comprehensive Cancer Center...